Shenzhen Capital

Shenzhen Capital

Shenzhen Capital was established in 1999 by the Shenzhen municipal government as a state-backed venture capital platform. Chairman Ni Zhendong and President Liu Bo have overseen its expansion into a cross-border technology investor with a portfolio exceeding 1,000 companies. The firm was created to channel domestic capital into Shenzhen's emerging tech sector, but has since broadened its mandate globally. The firm invests across the lifecycle — from seed to growth equity — with a focus on enterprise software, AI/ML, fintech, digital health, and climate tech. It structures investments through direct equity and fund commitments, often co-investing with other state-backed Chinese VCs and international limited partners. Public record shows portfolio holdings include BGI Genomics (gene sequencing) and Ubtech Robotics (humanoid robots). Geographically, Shenzhen Capital targets companies in China, the United States, and Israel, operating from offices in Menlo Park, Herzliya, San Rafael, and Boulder. Shenzhen Capital manages a reported $10B in assets under management, 2023) and employs over 200 professionals. It operates with a long-term, patient capital model typical of state-backed funds, with investment horizons extending beyond typical VC fund terms. Recent activity includes leading a $150M Series C round for a Shenzhen-based AI chip startup in 2024. A structural differentiator is Shenzhen Capital's dual mandate: it acts as a commercial venture capital firm while also serving as a strategic instrument of the Shenzhen government to foster local technology clusters. This allows it to participate in deals closed to purely commercial investors and offers portfolio companies access to municipal resources and regulatory pathways.